首页|参附注射液通过TLR4/NF-κB通路调控巨噬细胞极化减轻慢性心力衰竭炎症

参附注射液通过TLR4/NF-κB通路调控巨噬细胞极化减轻慢性心力衰竭炎症

扫码查看
研究参附注射液对慢性心力衰竭小鼠的治疗作用及其对巨噬细胞极化的影响。将C57BL/6J小鼠随机分为正常组、造模组。通过腹腔注射异丙肾上腺素(ISO,7。5 mg·kg-1,28 d)建立心力衰竭模型,通过检测心功能、N-端前脑钠肽(NT-pro-BNP)判断模型是否复制成功。将造模成功的小鼠随机分为模型组、参附注射液(SFI)组、TAK-242组,并予以相应药物腹腔注射15 d。利用超声心动图评价心脏功能;HE染色检测病理形态;ELISA检测血清NT-proBNP、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、白细胞介素-10(IL-10)、精氨酸1(Arg-1)水平;流式细胞术检测心脏巨噬细胞相对含量及M1/M2极化状态;qPCR、Western blot检测Toll样受体4(TLR4)/核因子-κB(NF-κB)通路相关mRNA及蛋白表达变化。结果显示,与正常组比较,模型组小鼠左室射血分数(LVEF)、短轴缩短分数(LVFS)降低,左室舒张末内径(LVIDd)、左室收缩末内径(LVIDs)、NT-proBNP、TNF-α、IL-6 升高(P<0。01);心脏组织中巨噬细胞数量增多(P<0。05),M1-F4/80+CD86+值上升(P<0。01),M2-F4/80+CD163+值下调(P<0。05);心肌组织TLR4、髓样分化因子88(MyD88)、IκB激酶α(IKKα)、NF-κB p65 mRNA及蛋白表达升高(P<0。05,P<0。01)。与模型组比较,SFI 组、TAK-242 组小鼠 LVEF、LVFS、IL-10、Arg-1 升高,LVIDd、LVIDs、NT-proBNP、TNF-α、IL-6 降低(P<0。05,P<0。01);心脏 F4/80+CD11b+(巨噬细胞)、M1-F4/80+CD86+值下调,M2-F4/80+CD163+值上升(P<0。01,P<0。05);心肌组织TLR4、MyD88、IKKα、NF-κB p65 mRNA及蛋白表达降低(P<0。05,P<0。01)。综上,慢性心力衰竭小鼠存在M1/M2型巨噬细胞极化失衡,以M1型巨噬细胞为主;参附注射液可通过调控TLR4/NF-κB信号通路,促进巨噬细胞向M2极化,抑制M1型巨噬细胞活化,减轻心力衰竭炎症反应。
Shenfu Injection regulates macrophage polarization via TLR4/NF-κB pathway to reduce inflammation in chronic heart failure
This study aimed to investigate the therapeutic effect of Shenfu Injection on mice with chronic heart failure(CHF)and its effect on macrophage polarization.C57BL/6J mice were randomly assigned to the normal and model groups.The CHF model was es-tablished by intraperitoneal injection of isoproterenol(ISO,7.5 mg·kg-1,28 d).The successful modeling was determined by asses-sing the cardiac function and N-terminal pro-brain natriuretic peptide(NT-proBNP).The modeled mice were randomly divided into the model group,Shenfu Injection group,and TAK-242 group,and were injected intraperitoneally with the corresponding drugs for 15 days.Cardiac function was evaluated using echocardiography.Hematoxylin-eosin(HE)staining was used to detect the pathomorpholo-gy.Enzyme-linked immunosorbent assay(ELISA)was used to detect the values of serum NT-proBNP,interleukin-6(IL-6),tumor necrosis factor-α(TNF-α),IL-10,and arginase 1(Arg-1).Flow cytometry was applied to detect the relative content and M1/M2 po-larization of cardiac macrophages.Quantitative polymerase chain reaction(qPCR)and Western blot were used to detect the changes in the Toll-like receptor 4(TLR4)/nuclear factor-KB(NF-κB)pathway-related mRNA and protein expressions.Compared with the nor-mal group,mice in the model group had lower values of left ventricular ejection fraction(LVEF)and left ventricular fractional shorte-ning(LVFS),higher values of left ventricular internal diastolic end-diastolic(LVIDd),left ventricular internal diastolic end-systolic(LVIDs),NT-proBNP,TNF-α,and IL-6(P<0.01);the number of macrophages increased in cardiac tissues(P<0.05),and the values of M1-F4/80+CD86+were increased(P<0.01),while the values of M2-F4/80+CD163+decreased(P<0.05);the mRNA and protein expressions of TLR4,myeloid differentiation factor 88(MyD88),IκB kinase α(IKKα),and NF-κB p65 in myocardial tissues were significantly elevated(P<0.05,P<0.01).Compared with the model group,mice in the Shenfu Injection and TAK-242 groups showed elevated LVEF,LVFS,IL-10,and Arg-1 levels,and decreased LVIDd,LVIDs,NT-proBNP,TNF-α,and IL-6 levels(P<0.05,P<0.01);the cardiac F4/80+CD11b+(macrophage)and M1-F4/80+CD86+values were significantly down-regulated,while M2-F4/80+CD163+values were increased(P<0.05,P<0.01);and the mRNA and protein expressions of TLR4,MyD88,IKKα,and NF-κB p65 in myocardial tissues were notably decreased(P<0.05,P<0.01).CHF mice have an imbalance of M1/M2 macrophage polarization,with M1-type macrophages predominating.Shenfu Injection promotes macrophage polarization towards M2,inhibits M1-type macrophage activation,and attenuates inflammatory responses in heart failure by regulating the TLR4/NF-κB signaling pathway.

chronic heart failureShenfu Injectionmacrophage polarizationTLR4/NF-κBinflammation

杨梦、谈宇权、张君宇、张垚、苏丽清、胡志希、胡思远

展开 >

湖南中医药大学中医学院,湖南长沙 410208

慢性心力衰竭 参附注射液 巨噬细胞极化 TLR4/NF-KB 炎症

国家自然科学基金项目湖南省教育厅科学研究项目青年项目湖南中医药大学校级课题

8227441221B0379Z2023XYJB13

2024

中国中药杂志
中国药学会

中国中药杂志

CSTPCD北大核心
影响因子:1.718
ISSN:1001-5302
年,卷(期):2024.49(13)